MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association Between Heterozygous Loss-of-Function Variants in the MCOLN1 Gene and α-Synucleinopathies

CX. Ying, XH. Chen, ZD. Cen, W. Luo (Hangzhou, China)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein

Category: Parkinson's Disease: Disease mechanisms

Objective: To evaluate the association between heterozygous loss-of-function variants in the MCOLN1 gene and α-synucleinopathies.

Background: Lysosomes play a crucial role in cellular waste disposal, and their dysfunction can lead to various diseases. Growing evidence suggests a strong link between lysosomal dysfunction and α-synuclein aggregation in PD and multiple system atrophy (MSA). TRPML1, a lysosomal cation channel encoded by the MCOLN1 gene, is crucial for lysosomal function, and its biallelic loss-of-function mutations cause mucolipidosis type IV (MLIV), a rare lysosomal storage disease characterized by neurological defects, progressive vision loss, and achlorhydria. However, the relationship between heterozygous MCOLN1 mutations and α-synucleinopathies remains further investigation.

Method: We conducted whole-genome sequencing on patients with early-onset Parkinson’s disease and other α-Synucleinopathies without known genetic variants. To evaluate the functional impact of mutant TRPML1 at the protein level, we performed immunofluorescence analysis and lysorecording.

Results: We identified a heterozygous MCOLN1 variant, c.943_945delCTC (p.L315del), in a male patient with early-onset Parkinson’s disease, who initially presented with bradykinesia in the left limbs at 43 years old. Additionally, we detected another heterozygous variant, c.1126G>A (p.E376K), in a female patient with MSA. She developed bradykinesia in the right limbs at age 55 and was diagnosed with probable MSA-C at 59 years old. Functional assays revealed that the p.L315del mutant TRPML1 failed to localize to lysosomes, while the p.E376K mutant exhibited a dramatic reduction in lysosomal current upon TRPML1 agonist stimulation.

Conclusion: This study identified two rare heterozygous variants in the MCOLN1 gene in patients with α-Synucleinopathies, and functional assays demonstrated that both resulted in a loss of function.

To cite this abstract in AMA style:

CX. Ying, XH. Chen, ZD. Cen, W. Luo. Association Between Heterozygous Loss-of-Function Variants in the MCOLN1 Gene and α-Synucleinopathies [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/association-between-heterozygous-loss-of-function-variants-in-the-mcoln1-gene-and-%ce%b1-synucleinopathies/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-between-heterozygous-loss-of-function-variants-in-the-mcoln1-gene-and-%ce%b1-synucleinopathies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley